Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance
Go back to Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance| (NASDAQ: TARS) | Delayed: 68.04 -0.84 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.88 | 52 Week High | $ | |||
| Open | $68.82 | 52 Week Low | $ | |||
| Day High | $68.82 | P/E | N/A | |||
| Day Low | $67.61 | EPS | $ | |||
| Volume | 93,755 | |||||

